Levy A - Search Results

1

Aldea M, Belkhir R, Colomba E, Blanchard P, Danlos FX, Botticella A, Terlizzi M, Deutsch E, Le Péchoux C, Planchard D, Michot JM, Besse B, Levy A. Aldea M, et al. Among authors: levy a. Front Immunol. 2022 Oct 24;13:920130. doi: 10.3389/fimmu.2022.920130. eCollection 2022. Front Immunol. 2022. PMID: 36353627 Free PMC article.

2

[Molecular targeted therapies in small-cell lung cancer].

Levy A, Malouf GG, Besse B, Massard C, Soria JC. Levy A, et al. Bull Cancer. 2010 May;97(5):535-45. doi: 10.1684/bdc.2010.1035. Bull Cancer. 2010. PMID: 20093224 Free article. Review. French.

3

[Rectal cancer].

Blanchard P, Levy A, Breunot J, Michaud S, Delmas V, Hennequin C. Blanchard P, et al. Among authors: levy a. Cancer Radiother. 2010 Nov;14 Suppl 1:S111-9. doi: 10.1016/S1278-3218(10)70014-7. Cancer Radiother. 2010. PMID: 21129653 French.

4

[Cell cycle, mitosis and therapeutic applications].

Levy A, Albiges-Sauvin L, Massard C, Soria JC, Deutsch E. Levy A, et al. Bull Cancer. 2011 Oct;98(9):1037-45. doi: 10.1684/bdc.2011.1382. Bull Cancer. 2011. PMID: 21669563 Free article. Review. French.

5

Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?

Bourgier C, Levy A, Vozenin MC, Deutsch E. Bourgier C, et al. Among authors: levy a. Cancer Metastasis Rev. 2012 Dec;31(3-4):699-712. doi: 10.1007/s10555-012-9381-9. Cancer Metastasis Rev. 2012. PMID: 22706781 Review.

6

Radiation therapy and immunotherapy: implications for a combined cancer treatment.

Levy A, Chargari C, Cheminant M, Simon N, Bourgier C, Deutsch E. Levy A, et al. Crit Rev Oncol Hematol. 2013 Mar;85(3):278-87. doi: 10.1016/j.critrevonc.2012.09.001. Epub 2012 Oct 1. Crit Rev Oncol Hematol. 2013. PMID: 23036459 Review.

7

Targeted therapy-induced radiation recall.

Levy A, Hollebecque A, Bourgier C, Loriot Y, Guigay J, Robert C, Delaloge S, Bahleda R, Massard C, Soria JC, Deutsch E. Levy A, et al. Eur J Cancer. 2013 May;49(7):1662-8. doi: 10.1016/j.ejca.2012.12.009. Epub 2013 Jan 8. Eur J Cancer. 2013. PMID: 23312391

8

The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts.

Deberne M, Levy A, Mondini M, Dessen P, Vivet S, Supiramaniam A, Vozenin MC, Deutsch E. Deberne M, et al. Among authors: levy a. Anticancer Drugs. 2013 Jul;24(6):599-608. doi: 10.1097/CAD.0b013e3283612a71. Anticancer Drugs. 2013. PMID: 23698251

9

Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma: in regard to Yang et al.

Levy A, Blanchard P, Daly-Schveitzer N, Tao Y. Levy A, et al. Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):811. doi: 10.1016/j.ijrobp.2013.04.039. Epub 2013 May 29. Int J Radiat Oncol Biol Phys. 2013. PMID: 23726003 No abstract available.

10

Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trials.

Levy A, Gomez-Roca C, Massard C, Planchard D, Albiges L, Bahleda R, Bourgier C, Deutsch E, Soria JC, Besse B. Levy A, et al. Onkologie. 2013;36(6):357-62. doi: 10.1159/000351257. Epub 2013 May 13. Onkologie. 2013. PMID: 23774150 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,134 results

Search Page